How many half-lives does it take to reach steady state?

For a drug with first-order kinetics given at a constant rate, steady state is reached in about 4 to 5 half-lives, when the level is 94% to 97% of its final value. Each half-life closes half of the remaining gap: about 50% after one half-life, 75% after two, 87.5% after three, 93.75% after four and about 97% after five. Reaching 90% takes about 3.3 half-lives.

How long does it take a drug to wash out after it is stopped?

Washout follows the same clock. After the last dose of a first-order drug, half of what remains is eliminated each half-life, leaving 50% after one, 25% after two, 12.5% after three, 6.25% after four and about 3% after five. Near-complete elimination therefore takes about 4 to 5 half-lives. Drugs with long half-lives need long washouts; for example, the fluoxetine label requires at least 5 weeks off fluoxetine before an MAOI is started.

Does doubling the dose change the time to steady state?

No. For a first-order drug, the time to steady state depends only on the half-life, which is set by clearance and volume of distribution. Doubling the maintenance dose or infusion rate doubles the steady-state concentration, because Css equals the dosing rate divided by clearance, but the level still takes about 4 to 5 half-lives to settle. Only a loading dose gets the concentration to target immediately.

What is the formula for half-life?

Half-life equals 0.693 times the volume of distribution divided by clearance (t1/2 = 0.693 x Vd / CL), where 0.693 is the natural log of 2. It can also be written as 0.693 divided by the elimination rate constant k, and k equals clearance divided by Vd. The formula holds for first-order elimination only. A larger Vd or a lower clearance means a longer half-life.

How does kidney failure change half-life and dosing?

Kidney failure lowers clearance of renally eliminated drugs, so the half-life lengthens and the drug takes longer to reach steady state and to wash out. Because the maintenance dose depends on clearance, it is reduced or given less often. The loading dose depends on volume of distribution, which is usually not much altered in stable chronic kidney disease, so it generally needs no adjustment. Digoxin is the classic example: its half-life rises from 1.5-2 days to 3.5-5 days in anuria, so its label calls for smaller maintenance doses and warns that steady state takes longer to reach.

When does the 4-5 half-life rule not apply?

The rule applies only to first-order kinetics. Drugs with zero-order (saturable) elimination, classically phenytoin, ethanol and high-dose aspirin, are removed at a constant amount per unit time, so their half-life changes with concentration and steady state cannot be predicted from dose alone. With phenytoin, a small dose increase at higher levels can cause a very large rise in serum concentration, which is why levels are monitored.

Half-Life and Steady State: The 4-5 Half-Life Rule (USMLE)

For a drug eliminated by first-order kinetics, steady state takes about 4-5 half-lives to reach, and washout after the last dose takes about 4-5 half-lives too: by then the level is 94-97% of the way there (90% takes about 3.3 half-lives). The clock depends only on the half-life, t½ = 0.693 × Vd ÷ CL, so changing the dose or infusion rate changes the steady-state level, not the time to reach it. A loading dose (Cp × Vd ÷ F) reaches the target at once; the maintenance dose (Cp × CL × τ ÷ F) decides where steady state sits. Zero-order drugs (phenytoin, ethanol, high-dose aspirin) break the rule.

The 5-second rule

Filling and emptying take the same time: about 4-5 half-lives to reach steady state, about 4-5 half-lives to wash out.
Dose changes the level, not the clock. Double the maintenance rate and the steady-state concentration (Css) doubles; the time to get there doesn't change.
Only clearance and volume of distribution move the clock. Lower clearance (renal or hepatic failure) or a bigger Vd means a longer half-life, so a longer wait in both directions.

The 50% staircase

Each half-life closes half of the remaining gap, whether you are climbing toward steady state on constant dosing or falling toward zero after the drug is stopped.

Half-lives elapsed	% of steady state reached	% of drug left after stopping
1	50%	50%
2	75%	25%
3	87.5%	12.5%
about 3.3	about 90%	about 10%
4	93.75%	6.25%
5	96.9%	3.1%

Mnemonic: 50, 75, 87, 94, 97. The math is simple: the fraction left after n half-lives is (½)ⁿ, and the fraction of steady state reached is 1 − (½)ⁿ. If the answer choices offer "4-5 half-lives," take it; "about 3.3" is right only when the stem asks for 90%.

Why the clock never changes: first-order kinetics

First-order elimination removes a constant fraction of drug per unit time, because the elimination rate is proportional to plasma concentration. The half-life is therefore the same at any dose.
Zero-order elimination removes a constant amount per unit time because the enzymes or transporters are saturated; the half-life is not constant. As concentrations rise and pathways saturate, elimination can shift from first-order toward zero-order.
At steady state, rate in equals rate out: dosing rate = CL × Css. So Css = infusion rate ÷ CL, or for repeated oral doses the average Css = (F × dose) ÷ (CL × τ). Double the rate and Css doubles; halve the clearance and Css doubles too.
How fast you approach Css depends only on the half-life. That is why the staircase is identical for every first-order drug; only the length of each step differs.

More on the two curves in zero-order vs first-order elimination.

The formulas, as standard references write them

Quantity	Formula	What to remember
Volume of distribution	Vd = amount of drug in body ÷ plasma concentration	Highly tissue-bound drugs have a low plasma level and a high Vd
Clearance	CL = rate of elimination ÷ plasma concentration = k × Vd	Total CL = renal + hepatic + other
Elimination rate constant	k = CL ÷ Vd	Fraction eliminated per unit time
Half-life	t½ = 0.693 ÷ k = 0.693 × Vd ÷ CL	First-order only; 0.693 is ln 2
Loading dose	LD = (Cp × Vd) ÷ F	Depends on Vd
Maintenance dose	MD = (Cp × CL × τ) ÷ F	Depends on CL; τ = dosing interval

Cp is the target plasma concentration and F is bioavailability (1 for IV drugs). Some references also divide by S, the fraction of a salt form that is active drug. Deeper dives: volume of distribution, clearance and bioavailability.

Loading dose vs maintenance dose

A loading dose fills the tank. It gets the concentration to target immediately, which matters when the half-life is long and waiting 4-5 half-lives is unsafe: amiodarone, digoxin and IV phenytoin are classic examples.
The maintenance dose sets the steady state. If the loading dose was too big or too small, the level still drifts to the maintenance-determined Css over the usual 4-5 half-lives.
Kidney disease: clearance falls, so half-life lengthens and the maintenance dose (or frequency) is reduced; the loading dose generally needs no adjustment in stable CKD because Vd is not much altered.
Liver disease: in severe disease, maintenance doses are reduced according to how much of the drug's clearance is hepatic; when ascites (or low albumin) raises Vd, the loading dose may need to go up while the maintenance dose goes down.
Large Vd, same clearance: a longer half-life.

Three drugs that make it real

Digoxin. Half-life is 1.5-2 days with normal kidneys and 3.5-5 days in anuria (FDA label). Without a loading dose, the label's dosing tables put steady state at about 7 days with a creatinine clearance of 100 mL/min and about 19 days at 10 mL/min. That is why the label offers a loading regimen, calls for smaller maintenance doses in renal impairment and warns that it takes longer to reach steady state.
Phenytoin. Average half-life is about 22 hours (range 7-42), and the label puts steady state at least 7-10 days after starting standard doses. Its metabolism saturates, so at higher levels small dose increases can cause very large rises in serum concentration. Treat it as the exception, not the rule.
Fluoxetine. Fluoxetine has a long elimination half-life, so the label requires at least 5 weeks after stopping fluoxetine before starting an MAOI (but only 14 days after stopping an MAOI before starting fluoxetine). Long half-life means long washout. See SSRIs vs MAOIs.

First-order vs zero-order at a glance

	First-order (most drugs)	Zero-order (saturated)
Eliminated per unit time	Constant fraction	Constant amount
Half-life	Constant	Varies with concentration
Time to steady state	4-5 half-lives	Rule doesn't apply; levels aren't predictable from dose alone
Dose doubled	Css doubles	Css can rise far more than double
Examples	Most clinically used drugs	Phenytoin, Ethanol, Aspirin (high doses): "PEA"; also methanol and theophylline

Zero-order medicines such as phenytoin need level monitoring because concentrations can't be predicted from dose alone. Related: therapeutic index and narrow-margin drugs.

How USMLE tests it

"Doubling the dose halves the time to steady state." False: the time is still 4-5 half-lives.
"Dosing more often reaches steady state sooner." False. Splitting the same daily dose into smaller, more frequent doses narrows the peak-trough swing; giving the same dose at a shorter interval raises the dosing rate and the average Css. Neither changes the timing.
Stopping a drug: after 3 half-lives, 12.5% remains; after 5, about 3%.
Renal failure (stable CKD): usually the same loading dose, smaller maintenance dose, longer half-life, longer wait to steady state and to washout.
Tissue-bound drug with a huge Vd: long half-life (for a given clearance), and a loading dose is often used.
Ethanol: its metabolism saturates even at moderate blood levels, so a fixed amount is cleared per hour regardless of concentration.

Practice question

A 58-year-old man in the ICU receives a continuous IV infusion of a drug that follows first-order kinetics and has a half-life of 8 hours. After 48 hours at a constant rate, his plasma concentration is stable at 10 mg/L. The infusion rate is then doubled, and his clearance does not change. Which best describes his plasma concentration after the change?

A. It doubles to 20 mg/L immediately B. It rises toward 20 mg/L and is essentially there in about 32-40 hours C. It rises toward 20 mg/L and is essentially there in about 16-20 hours D. It rises toward 40 mg/L over about 32-40 hours E. It keeps rising without reaching a plateau

Answer: B. At steady state, Css = infusion rate ÷ CL, so doubling the rate doubles the target to 20 mg/L. The approach to the new plateau follows the same half-life, so it takes 4-5 half-lives (4-5 × 8 hours = 32-40 hours) to get 94-97% of the way.

A: only a bolus jumps the level at once. To reach 20 mg/L immediately you would add an extra loading dose of (20 − 10) mg/L × Vd.
C: a higher rate raises the target, not the speed; only a shorter half-life (higher CL or smaller Vd) would get there faster.
D: first-order kinetics are linear: Css is proportional to the dosing rate, so twice the rate gives twice the level, not four times.
E: an endless climb happens only when elimination is saturated (zero-order) and intake exceeds the maximum elimination rate; a first-order drug always plateaus.

Key takeaways

4-5 half-lives to reach steady state and 4-5 half-lives to wash out (94-97%); 90% takes about 3.3.
50, 75, 87, 94, 97: percent of steady state after 1-5 half-lives.
t½ = 0.693 × Vd ÷ CL. Low clearance or a large Vd means a long half-life.
Dose sets the level; half-life sets the clock. Double the rate, double Css, same timing.
LD = Cp × Vd ÷ F (gets you there now); MD = Cp × CL × τ ÷ F (keeps you there).
Kidney failure: usually keep the loading dose, cut the maintenance dose, expect a longer wait.
PEA (phenytoin, ethanol, high-dose aspirin) follow zero-order kinetics, so the shortcut fails.